These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34609382)
41. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463 [TBL] [Abstract][Full Text] [Related]
42. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. Dranitsaris G; Ellis AK J Eval Clin Pract; 2014 Jun; 20(3):225-38. PubMed ID: 24444390 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma. Roxbury CR; Lin SY Otolaryngol Clin North Am; 2017 Dec; 50(6):1111-1119. PubMed ID: 28964530 [TBL] [Abstract][Full Text] [Related]
44. Approach to Patients with Allergic Rhinitis: Testing and Treatment. Cox L Med Clin North Am; 2020 Jan; 104(1):77-94. PubMed ID: 31757239 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885 [TBL] [Abstract][Full Text] [Related]
46. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025 [TBL] [Abstract][Full Text] [Related]
47. How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma? Larenas-Linnemann D; Morfin Maciel BM Expert Rev Respir Med; 2023; 17(8):717-725. PubMed ID: 37642332 [TBL] [Abstract][Full Text] [Related]
48. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial. Demoly P; Corren J; Creticos P; De Blay F; Gevaert P; Hellings P; Kowal K; Le Gall M; Nenasheva N; Passalacqua G; Pfaar O; Tortajada-Girbés M; Vidal C; Worm M; Casale TB J Allergy Clin Immunol; 2021 Mar; 147(3):1020-1030.e10. PubMed ID: 32890575 [TBL] [Abstract][Full Text] [Related]
49. Clinical considerations in the use of sublingual immunotherapy for allergic rhinitis. Lee S; Nolte H; Benninger MS Am J Rhinol Allergy; 2015; 29(2):106-14. PubMed ID: 25785750 [TBL] [Abstract][Full Text] [Related]
50. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens. Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116 [TBL] [Abstract][Full Text] [Related]
51. Long-term efficacy of injected allergen immunotherapy for treatment of grass pollen allergy in elderly patients with allergic rhinitis. Bozek A; Cudak A; Walter Canonica G Allergy Asthma Proc; 2020 Jul; 41(4):271-277. PubMed ID: 32605697 [No Abstract] [Full Text] [Related]
52. Allergen immunotherapy effectiveness in specific nasal reactivity of children with local allergic rhinitis. Loureiro G; Tavares B; Farinha I; Cunha F; Todo-Bom A Eur Ann Allergy Clin Immunol; 2024 Sep; ():. PubMed ID: 39219549 [No Abstract] [Full Text] [Related]
53. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting. Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466 [TBL] [Abstract][Full Text] [Related]
54. Sublingual Versus Subcutaneous Immunotherapy for Allergic Rhinitis: What Are the Important Therapeutic and Real-World Considerations? Field K; Blaiss MS Curr Allergy Asthma Rep; 2020 Jun; 20(9):45. PubMed ID: 32548677 [TBL] [Abstract][Full Text] [Related]
55. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial. Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865 [TBL] [Abstract][Full Text] [Related]
56. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial. Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762 [TBL] [Abstract][Full Text] [Related]
57. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Nurmatov U; Dhami S; Arasi S; Pajno GB; Fernandez-Rivas M; Muraro A; Roberts G; Akdis C; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; du Toit G; Ebisawa M; Eigenmann P; Knol E; Makela M; Nadeau KC; O'Mahony L; Papadopoulos N; Poulsen LK; Sackesen C; Sampson H; Santos AF; van Ree R; Timmermans F; Sheikh A Allergy; 2017 Aug; 72(8):1133-1147. PubMed ID: 28058751 [TBL] [Abstract][Full Text] [Related]
58. Immunotherapy in allergic rhinitis and lower airway outcomes. Cardona V; Luengo O; Labrador-Horrillo M Allergy; 2017 Jan; 72(1):35-42. PubMed ID: 27439141 [TBL] [Abstract][Full Text] [Related]
59. Preventive capacity of allergen immunotherapy on the natural history of allergy. Incorvaia C J Prev Med Hyg; 2013 Jun; 54(2):71-4. PubMed ID: 24396984 [TBL] [Abstract][Full Text] [Related]
60. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis. Wang ZX; Shi H J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]